Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
HB Ventures, also known as 木槿资本, is a venture capital firm based in Vienna, Austria. Founded by experienced entrepreneurs and bankers, the firm focuses on early and growth stage technology companies. They manage a portfolio of 9 companies and target investments ranging from $1 million to $5 million.
HB Ventures invests in sectors such as artificial intelligence, web3, biotech, healthcare, energy, and fintech. Their investment strategy emphasizes scalable businesses with sustainable models, primarily targeting opportunities in Greater China and Southeast Asia, while also considering the US and Europe.
Notable portfolio companies include ChangYi, a WeChat-based enterprise solutions provider; Yizhu Technology, specializing in semiconductor design; and Pillar Biosciences, focused on DNA sequencing workflows. Other investments include Laekna Therapeutics, E-Tronic, Leto Laboratories, MDHC, Shanghai Yilei, and Chengdu Zhongweida Xinko Technology.
YT Tsoi is the CEO & Founder, bringing extensive entrepreneurial experience. Kayla Yuen serves as Managing Director, focusing on investment strategy and portfolio management. Simon Zhou is a Director, specializing in technology investments.
To pitch HB Ventures, email your deck to contact@hbventures.com.
Yes, HB Ventures often leads investment rounds, particularly in early and growth stage companies that align with their focus sectors.
HB Ventures is open to follow-on investments in portfolio companies that demonstrate continued growth and traction.
The specific size of HB Ventures' current fund is not publicly disclosed, but they typically invest between $1 million and $5 million per company.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.